Alzamend Neuro Inc (ALZN) vs Lunai Bioworks Inc. (LNAI)

A side-by-side comparison of Alzamend Neuro Inc and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALZN

Alzamend Neuro Inc

$5M

$1.37HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT

LNAI

Lunai Bioworks Inc.

$5M

$1.15HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT

Total return — ALZN vs LNAI

growth of $100 · dividends reinvested · last 1y

ALZN -41.7% (-41.7%/yr)LNAI -93.8% (-93.8%/yr)ALZN compounded faster over this window

Log scale — wide-divergence pair

ALZN LNAI

ALZN vs LNAI: by the numbers

•LNAI is the larger company ($5M vs $5M market cap).
•Both run net losses; ALZN's is the smaller (0.00% vs -612568.11% net margin).

Metrics side by side

Valuation

Metric	ALZN	LNAI
P/S ratio	N/A	248.97
P/B ratio	0.90	N/A

Profitability

Metric	ALZN	LNAI
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-612568.11%
ROE	-156.77%	N/A
ROIC	-156.69%	N/A

Growth (annualized)

Metric	ALZN	LNAI
Total return CAGR (5Y)	-79.14%	N/A

Go deeper

Full ALZN analysis Full LNAI analysis Interactive comparison tool

Dig into the metrics

Alzamend Neuro ROE Lunai Bioworks ROE Alzamend Neuro operating margin Lunai Bioworks operating margin Alzamend Neuro revenue growth Lunai Bioworks revenue growth Alzamend Neuro free cash flow Lunai Bioworks free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.